Know what's inside.


With Steffen Walter as the New Co-CEO, the GBA Laboratory Group Initiates the Process of Transferring Leadership
The management, the advisory board, and the partners of the GBA Laboratory Group are pleased to announce today that the management team has been strengthened even further. Starting January 2018, Steffen Walter, as Co-CEO of GBA Holding GmbH, is responsible for the Pharmaceutical and Environmental Divisions and will be coordinating the implementation of the strategy for growth and international expansion in both of these fields, as well as the administration, purchasing, HR, and digitalization. more

With his long-term managerial experience in the field, he not only enhances the existing management team, but as Co-CEO, he also steps in as the successor to Manfred Giesecke, who had previously been serving as the sole CEO.

Having graduated from the Karlsruhe Institute of Technology (KIT) with a degree in Business & Engineering (Dipl.-Wirtschaftsingenieur), Steffen Walter began his career as a managerial assistant at the German Mechanical Engineering Industry Association (VDMA). He has been involved in the laboratory and TIC field since 2001. His start as the assistant to the board of directors at Institut Fresenius was followed up by positions of leadership within the SGS Group in Germany. In 2007 he assumed the responsibility for the operational and commercial activities concerning the laboratories, inspection, and certification in the following fields: non-food, food, electrics & electronics, and automotive. Before switching to the GBA Laboratory Group, he served as General Manager and a member of the European Management Board for the Eurofins Food Division in Germany and Turkey for several years.

We are looking forward to working together with Steffen Walter and we would like to wish him a warm welcome to the company.

INSTITUT PIELDNER Dienst­leistungsinstitut für Lebens­mittelqualität GmbH, Based in Stuttgart, Will Become a Member of the GBA Laboratory Group
INSTITUT PIELDNER was founded in 1974. Today it is under the second ge­neration of Pieldner family lea­dership, mana­ged by Horst U. Pield­ner. The service portfolio includes foodstuff analysis (chemical and microbiological analyses, in particular aller­gens and legionella, as well as sensory tests), but also consulting services, on-site services, training programs, and seminars. more

The GBA Group has now recorded its third merger since last fall. This fact clearly illustrates the ambitions of the GBA Laboratory Group – a medium-sized company for food analysis, environmental analysis, pharmaceutical analysis, and consumer goods analysis – to expand and become one of the leading companies on the Ger­man laboratory market. INSTITUT PIELDNER, based in Stuttgart, is an institute that provides food quality services and has an excellent reputation among its custo­mers as well as a long history of highly qualified and reliable foodstuff analysis. Therefore we are pleased to welcome INSTITUT PIELDNER to the GBA Group. This goes for all of the employees of the institute, but for Mr. Pieldner in particular, as he will continue to play an important role in the management of the GBA Division for Food Analysis and thus become a core member of the GBA Group. The inde­pendence of INSTITUT PIELDNER will be maintained as it was before; it will only be supplemented by certain group functions in order to strengthen its presence on the market.

Horst U. Pieldner, CEO and executive partner of INSTITUT PIELDNER, emphasizes: 

“With this merger, we will bring our current strengths in analysis and consulting to the group and also profit from the GBA Group’s expertise in other fields that are interesting for us as well. Furthermore, as a service institute that operates nation­wide, this will also result in the optimization of our potential in terms of the quality of service we provide both our new and long-term customers, in connection with faster processing times and reaction times. The entire IPDP team is looking for­ward to this exchange of know-how concerning our combined analytical service portfolio.”

Manfred Giesecke, CEO of the GBA Laboratory Group, adds: “For the GBA Labora­tory Group, this merger is an outstanding case, both in terms of the content and the culture. On behalf of all GBA employees, we welcome our new colleagues in Stuttgart. The high quality of analysis, the equally strong focus on providing the best possible customer service, the shared potential for expanding the range of services in the field of food analysis, as well as the regional expansion to the loca­tion in Stuttgart – in the heart of southern Germany – provided further key factors for this merger.”

The parties have agreed that the details of the merger are not to be disclosed.

Please address any further questions to:

GBA Laboratory Group                        INSTITUT PIELDNER 
Frau Sabine Nest                                     Frau Romy Marienthal

The 42nd German Federal Immission Control Act (BImSchV) Takes Effect
Evaporative cooling systems, cooling towers, and wet scrubber systems can repre­sent a source of aerosols that may contain legionella. The fatal cases of legionella infections that are known throughout Germany, such as those in Ulm (2010), Warstein (2013), and Bre­men (2016), have led to the measures presen­ted in the 42nd Immission Control Act. more

In order to minimize the risk of adverse health effects, this act regulates the operation, production, and installation of such systems. The result is that the operators have the duty to register and mo­nitor their systems.

This regulation provides a legal framework that is precautionary and protective in nature and is legally binding as of August 19th, 2017. This regulation im­plements the state of technology described in the guideline VDI-2047 sheets 2 and 3 as well as in the recommendation from the German environmental protection agency (Umweltbundesamt/UBA) for the sampling and detection of legionella in eva­porative cooling systems, cooling towers, and wet scrubbers.

The operators of such systems are now subject to the following requirements:

• Declare existing systems and new systems to the responsible authorities
• Conduct a risk assessment that gathers the potential threats concerning
   hygiene and safety and determines the appropriate measures deriving
   from them
• Maintain an operational logbook
• Regularly have the systems checked by an authorized appraiser
• Regular microbiological, physical, and chemical testing of the system
   water conducted internally
• Regular testing for legionella and total plate count conducted by a
   laboratory accredited according to DIN EN ISO/IEC 17025

As an accredited laboratory, the GBA Laboratory Group has been working in­tensively to establish challenging microbiological analyses over the last 18 months. According to the recommendation issued by the UBA, one year after the regulation goes into effect, the laboratories must possess an accreditation especially for this kind of water analysis. The GBA Labora­tory Group already accomplished this in the fall of 2016, so we can fully meet the high demands of these regulations, ranging from uniform sampling, to analysis and evaluation, as well as reporting the results.

Furthermore, there is also the requirement to integrate the sample-takers into the laboratory’s quality management system (QMS). That’s why we have expan­ded our system for external samplers in the drinking water sector, which the GBA Labora­tory Group has been using successfully for many years. In the up­coming months, the capacity will be expanded in order to provide them with the appropriate trai­ning.

If you have any questions, please get in touch with your individual GBA custo­mer service representative, or:

GBA Gesellschaft für Bioanalytik mbH
Dr. Sven Steinhauer
Tel: +49 (0)40 797172-0

Pharmaceutical Quality Control: Tips, Tools & Tactics - Seminar with Dr. Xaver Schratt
On April 6th and 7th, a seminar will be held by LGC in Potsdam about the topic of “Pharmaceutical Quality Control: Tips, Tools & Tactics.” Dr. Xaver Schratt, member of GBA Laboratory Group’s site of LPU in Martinsried, Germany, will be reporting on practical aspects of validating analytical methods in the pharmaceutical field. The main focus will be placed on commonly occurring errors and how they can be avoided. Furthermore, common misunderstandings will be discussed and explained using practical examples. more

Key issues in this field will be discussed, such as calculating “peak purity” as well as sound acceptance criteria in the context of validating the specificity. Additionally, the interaction between various analytical techniques as evidence of the specificity will be illustrated using a specific case study. Further examples will deal with qualifying the reference-standard materials and establishing response factors.

Further information can be found at: "Pharmaceutical Quality Control: Tips, Tools & Tactics".

Pharmacelsus GmbH, in Saarbrücken, Has Become a Member of the GBA Laboratory Group
In February, we were successful in ac­quiring Pharmacelsus GmbH, located in Saarbrücken, Germany, as new member of the GBA Laboratory Group, further expanding our range of services in the pharmaceutical field. Pharmacelsus is an internationally operating contract research organi­zation that has been offering precli­nical services in the fields of in-vitro ADME/T, in vivo pharmacoki­netics and pharmacology, as well as bioanalysis (GLP and non-GLP) for over 15 years. more

The Pharmacelsus portfolio covers the entire preclinical testing program for the development of new active ingredients based on low-molecular substances, as well as GCLP bioanalysis of clinical samples. Its customer base consists of pharma­ceutical and biotech companies as well as academic institutes.

Besides providing us with an additional lab site in Germany, for the GBA Labora­tory Group, this expansion enables us to make use of further synergies that will enable us to offer our clients the full potential of an even more extensive range of services, all from one source.

If you have any questions about Pharmacelsus or about the GBA Laboratory Group’s expanded range of services in the pharmaceutical field, then please feel free to contact us:

Pharmacelsus GmbH
Science Park 2
66123 Saarbrücken, Deutschland
Tel: +49 (0)681 3946 7510
Or at:

The GBA Laboratory Group Supports German Foundation for Children with Cancer
As we begin the new year, one special project has been near and dear to our hearts at the GBA Laboratory Group. With our Christmas donation of € 10,000, we supported the Waldpiraten or “Forest Pirates” Camp, a project run by the Deutsche Kinderkrebsstiftung, the German foundation for children with cancer. more

During the school vacation, special activities are offered for children and adole­scents with cancer, as well as their siblings. Under the leadership of trained coun­selors, the camp offers everything that helps them recover from this severe disea­se and to find new courage in life. Furthermore, part of the money flows into a social fund that provides financial support for families that have run into financial hardship due to their child’s cancer.

With this donation, we are pleased that we are able to help make a positive impact! 

Disposal of Insulating Materials Containing HBCD – German Government Grants Deferral
In our September 2016 newsletter, we reported on the ban on the production and circulation of products containing over 100 mg/kg of the flame retardant hexabro­mocyclododecane (HBCD). more

Furthermore, as of September 30th, 2016, materials containing over 1,000 mg/kg are no longer allowed to be recycled. Instead, they should be destroyed in muni­cipal waste incineration plants in accordance with Art. 7 (2) of the POP Regulation (EC) No 850/2004.

In certain German federal states, however, the application of the regulation tends to impede rather than promote the desired method of disposal. In some cases, the material cannot be incinerated due to its classification as “hazardous waste” (e.g. in cement plants in Rhineland-Palatinate). Moreover, many waste management com­panies and incineration plants either cannot accept this waste anymore or only at excessive prices, because this waste doesn’t fit within their logistical concept or the functionality of the facility. Due to this, housing companies in particular have prob­lems disposing of the insulating material in accordance with the legal require­ments.

Therefore, on December 16th, 2016, based on a proposal from Saarland, the Ger­man Bundesrat decided on a draft to amend the regulation on the European List of Waste. It is indisputable that HBCD is hazardous to the environment and must be removed from circulation. However, in order to counteract this problem, a one-year exemption should be issued for materials containing HBCD. This is meant to allow for a sustainable solution to be found, for a concept to be generated, and, where necessary, for the waste incineration plants to be upgraded appropriately. Nevertheless, it is not intended to mean that materials contain HBCD should once again be classified as nonhazardous. The exemption merely serves to help meet the legal requirements for disposing of these materials in the future.

For years, the GBA Laboratory Group has been conducting analyses of a wide range of organic and inorganic flame-retardants in diverse matrices. In addition to testing heat insulation and electronic products, we also analyze these substance groups in sediment, water, soil, and biota samples, even at trace levels. Furthermore, we follow the latest developments on the market for you, so that we may continue to support you with competent advice and service.

[2] Plenarprotokoll-952.pdf?__blob=publicationFile&v=2

Displaying news 43 to 49 out of 75